AU2002366544A1 - Adjuvant formulations for bacterial and virus vaccines and method of making same - Google Patents
Adjuvant formulations for bacterial and virus vaccines and method of making sameInfo
- Publication number
- AU2002366544A1 AU2002366544A1 AU2002366544A AU2002366544A AU2002366544A1 AU 2002366544 A1 AU2002366544 A1 AU 2002366544A1 AU 2002366544 A AU2002366544 A AU 2002366544A AU 2002366544 A AU2002366544 A AU 2002366544A AU 2002366544 A1 AU2002366544 A1 AU 2002366544A1
- Authority
- AU
- Australia
- Prior art keywords
- bacterial
- making same
- virus vaccines
- adjuvant formulations
- adjuvant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30813901P | 2001-07-27 | 2001-07-27 | |
US60/308,139 | 2001-07-27 | ||
PCT/US2002/023765 WO2003049670A2 (en) | 2001-07-27 | 2002-07-26 | Adjuvant formulations for bacterial and virus vaccines and method of making same |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2002366544A8 AU2002366544A8 (en) | 2003-06-23 |
AU2002366544A1 true AU2002366544A1 (en) | 2003-06-23 |
Family
ID=23192713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002366544A Abandoned AU2002366544A1 (en) | 2001-07-27 | 2002-07-26 | Adjuvant formulations for bacterial and virus vaccines and method of making same |
Country Status (5)
Country | Link |
---|---|
US (2) | US20050148538A1 (en) |
EP (1) | EP1465639A4 (en) |
AU (1) | AU2002366544A1 (en) |
CA (1) | CA2493444A1 (en) |
WO (1) | WO2003049670A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070082863A1 (en) * | 2003-04-29 | 2007-04-12 | Signorelli Kathy L | Methods and compositions for maturing dendritic cells utilizing inosine-containing compounds |
KR20060096415A (en) * | 2003-09-05 | 2006-09-11 | 애나디스 파마슈티칼스, 인코포레이티드 | Administration of tlr7 ligands and prodrugs thereof for treatment of infection by hepatitis c virus |
EP1735338B1 (en) | 2004-02-11 | 2013-04-24 | Ligocyte Pharmaceuticals, Inc. | Anthrax antigens and methods of use |
EP1747672A4 (en) * | 2004-05-19 | 2010-02-17 | Alza Corp | Method and formulation for transdermal delivery of immunologically active agents |
CN101060852A (en) * | 2004-08-17 | 2007-10-24 | 亨特免疫有限公司 | Oral inactivation vaccine and its delivery method |
GB201105981D0 (en) * | 2011-04-08 | 2011-05-18 | Glaxosmithkline Biolog Sa | Novel process |
WO2014096958A1 (en) | 2012-11-02 | 2014-06-26 | Academisch Medisch Centrum | Inosine monophosphate and salts thereof for use in the treatment of complement-related disorders |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4475196A (en) | 1981-03-06 | 1984-10-02 | Zor Clair G | Instrument for locating faults in aircraft passenger reading light and attendant call control system |
US4447233A (en) | 1981-04-10 | 1984-05-08 | Parker-Hannifin Corporation | Medication infusion pump |
US4439196A (en) | 1982-03-18 | 1984-03-27 | Merck & Co., Inc. | Osmotic drug delivery system |
US4447224A (en) | 1982-09-20 | 1984-05-08 | Infusaid Corporation | Variable flow implantable infusion apparatus |
US4487603A (en) | 1982-11-26 | 1984-12-11 | Cordis Corporation | Implantable microinfusion pump system |
US4486194A (en) | 1983-06-08 | 1984-12-04 | James Ferrara | Therapeutic device for administering medicaments through the skin |
US5614504A (en) * | 1990-08-01 | 1997-03-25 | The University Of South Florida | Method of making inosine monophosphate derivatives and immunopotentiating uses thereof |
CA2675757C (en) * | 1995-04-21 | 2011-03-15 | University Of South Florida | Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof |
-
2002
- 2002-07-26 CA CA002493444A patent/CA2493444A1/en not_active Abandoned
- 2002-07-26 US US10/500,602 patent/US20050148538A1/en not_active Abandoned
- 2002-07-26 AU AU2002366544A patent/AU2002366544A1/en not_active Abandoned
- 2002-07-26 WO PCT/US2002/023765 patent/WO2003049670A2/en not_active Application Discontinuation
- 2002-07-26 EP EP02804668A patent/EP1465639A4/en not_active Ceased
-
2012
- 2012-10-23 US US13/658,518 patent/US20130171192A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1465639A2 (en) | 2004-10-13 |
WO2003049670A3 (en) | 2003-11-06 |
US20050148538A1 (en) | 2005-07-07 |
WO2003049670A2 (en) | 2003-06-19 |
AU2002366544A8 (en) | 2003-06-23 |
US20130171192A1 (en) | 2013-07-04 |
CA2493444A1 (en) | 2003-06-19 |
EP1465639A4 (en) | 2006-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1357938B8 (en) | Hyperblebbing bacterial strains and use thereof for production of vaccines | |
AU2001255196A1 (en) | Compositions and methods for enhancing immunogenicity of antigens | |
AU2002348319A1 (en) | Toneable conduit and method of preparing same | |
AU2002329915A1 (en) | Methods for sterilizing preparations of digestive enzymes | |
AU2002332020A1 (en) | Compositions for oral gene therapy and methods of using same | |
AU2002360473A1 (en) | Method for preparation of three-demensional bodies | |
AU2003235707A1 (en) | Immunogenic preparations and vaccines on the basis of mrna | |
AU2001241918A1 (en) | Methods of enhancing activity of vaccines and vaccine compositions | |
AU2002306577A1 (en) | Targeting system and method of targeting | |
AU2003270779A1 (en) | Vaccine compositions and adjuvant | |
AU2002326751A1 (en) | Immunoglobulin e vaccines and methods of use thereof | |
AU2002335815A1 (en) | High-concentration protein formulations and method of manufacture | |
AU2003259374A1 (en) | Vaccine comprising il-13 and an adjuvant | |
AU2002258979A1 (en) | Method of preparing and formulations including hydrolyzed jojoba protein | |
AU2002366544A1 (en) | Adjuvant formulations for bacterial and virus vaccines and method of making same | |
AU2003278175A1 (en) | Vaccines of enhanced immunogenicity, and methods for preparing such vaccines | |
AU2001290834A1 (en) | System and method for computerized ordering of vaccines | |
AU2002324753A1 (en) | Composition and method for treating viral infection | |
EP1578723A3 (en) | Process for the preparation of oxazolidinones and method of use thereof | |
AU2002367959A1 (en) | Process for the preparation of oxazolidinones and method of use thereof | |
AU2001295672A1 (en) | Vaccine composition and stabilisation method | |
AU2002347464A1 (en) | Anti-arthropod vector vaccines methods of selecting and uses thereof | |
AU2002217820A1 (en) | Method and compositions of defensin-antigen fusion proteins and chemokine-antigen fusion proteins as vaccines for tumors and viral infection | |
AU2002364696A1 (en) | Crystalline neutrokine-alpha protein, method of preparation thereof, and method of use thereof | |
AU2001256675A1 (en) | Method of preparing virus vector |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |